Maja Orešnik, Science & Research Director of PharmaLinea shared her view: “We are very pleased with the results as iron sulphate represents a benchmark in efficacy and is very commonly prescribed or taken – both in iron supplements and in iron drugs. As such, the substantially higher increase in serum ferritin by >Your< Iron Syrup is very impressive. Also, these results reinforce the findings of the clinical trial, both in the excellent performance of >Your< Iron Syrup in improving ferritin status, as well as restoring other iron-related markers to healthy levels. Research on the effects of iron supplementation on the inhibition of absorption through hepcidin is also coming into the spotlight. We are happy to have investigated these mechanisms in relation to our product line and to have shown very positive results.”